Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Re-Treatment with Daclatasvir and Asunaprevir in Chronic Hepatitis C
NCT01428063Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Sep 2011
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 2 trial of daclatasvir, asunaprevir in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Sep 2011; status: completed.
02
Drugs
daclatasvirasunaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01428063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01428063.